INO compared with EQ: revenue, margins and what each company keeps, and the suppliers and customers both name

INOInovio Pharmaceuticals, Inc.

Mkt capRevenueRevenue

EQEquillium, Inc.

Mkt capRevenueRevenue

Compare

INOInovio Pharmaceuticals, Inc.

EQEquillium, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

INOInovio Pharmaceuticals, Inc.

0.62▼−20.32%· post 2.05

Mkt cap$62.3MRevenue$65,343Q1 FY25Revenue—

EQEquillium, Inc.

1.38▼−2.90%· post 1.38

ClosedOct 30 '26

Mkt cap$86.9MRevenue$4MQ4 FY24Revenue$41MFY24

Compare

ClosedOct 30 '26

INOInovio Pharmaceuticals, Inc.

EQEquillium, Inc.

0.62▼−20.32%post 2.05

Price

1.38▼−2.90%post 1.38

$62.3M

Mkt cap

$86.9M

Q1 FY25$65,343

Revenue

$4MQ4 FY24

—

Revenue

$41MFY24

INO0.62▼−20.32%vsEQ1.38▼−2.90%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

INO, solidEQ, dashed

Supply-chain overlap

Revenue flow

INO: latest quarter is a loss; flow not drawable. EQ: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only INO 7

—ApolloBiounlistedcustomer

CHRSCoherus BioSciencessupplier

—Vgxiunlistedsupplier

—Defense Advanced Research Projects Agency (DARPA)unlistedcustomer

3 more · INO chain ›

Shared 0

No shared counterparties.

Only EQ 2

—Bioconunlistedsupplier

—Ono Pharmaceuticalunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR